Remove Antibody Remove Gene Family Remove Medicine
article thumbnail

Clinical Data From Full Phase 1 Cohort Of Investigational Sotorasib Published In New England Journal Of Medicine

The Pharma Data

20, 2020 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that updated data from the full Phase 1 cohort of the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510) in 129 patients across multiple advanced solid tumors, were published in the New England Journal of Medicine (NEJM). THOUSAND OAKS, Calif.

article thumbnail

Study offers insights on why the elderly are more susceptible to COVID-19

The Pharma Data

Elias, an immunologist and dean of medicine and biological sciences at Brown. The researchers thought they might be able to take some of the work they’ve already done with this gene family and apply it to COVID-19, Elias said. “This means there will be less infection in the presence of this therapeutic FRG antibody.”